Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Illumina    ILMN

ILLUMINA (ILMN)
Mes dernières consult.
Most popular
  Report  
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
OFFRE ETE Zonebourse : Jusqu'à 6 mois offerts sur tous les portefeuilles
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
06/18/2018 06/19/2018 06/20/2018 06/21/2018 06/22/2018 Date
288.85(c) 285.74(c) 287.65(c) 286.05(c) 282.65(c) Last
665 327 794 604 651 101 442 086 2 007 614 Volume
+0.03% -1.08% +0.67% -0.56% -1.19% Change
More quotes
Financials (USD)
Sales 2018 3 183 M
EBIT 2018 826 M
Net income 2018 666 M
Finance 2018 1 353 M
Yield 2018 -
Sales 2019 3 588 M
EBIT 2019 984 M
Net income 2019 757 M
Finance 2019 1 843 M
Yield 2019 -
P/E ratio 2018 63,05
P/E ratio 2019 55,29
EV / Sales2018 12,6x
EV / Sales2019 11,1x
Capitalization 41 550 M
More Financials
Company
Illumina, Inc. engages in the development and manufacture of integrated systems for the analysis of genetic variation and function.It operates through the Core Illumina and Consolidated Variable Interest Entity segments (VIE).The Core Illumina segment serve customers in the research, clinical and... 
More about the company
Surperformance© ratings of Illumina
Trading Rating : Investor Rating :
More Ratings
Latest news on ILLUMINA
12:43pILLUMINA : $95,931 Federal Contract Awarded to Illumina
AQ
06/22Initiating Free Research Reports on DENTSPLY SIRONA and Three Other Medical S..
AC
06/21ILLUMINA : Comprehensive Maintenance Plan for cBot
AQ
06/15ILLUMINA : Acquires Edico Genome to Accelerate Genomic Data Analysis
AQ
06/09ILLUMINA : $224,400 Federal Contract Awarded to Illumina
AQ
06/07ILLUMINA : to Webcast Upcoming Investor Conference Presentations
AQ
06/07ILLUMINA : Patent Issued for Sequencing by Orthogonal Synthesis (USPTO 9982294)
AQ
06/06ILLUMINA : $190,562 Federal Contract Awarded to Illumina
AQ
06/04BIOINFORMATICS MARKET GROWING AT CAG : This research report on Bioinformatics Ma..
AQ
06/02ILLUMINA : HHS Awards Reagents Supply to Illumina
AQ
More news
Sector news : Advanced Medical Equipment & Technology - NEC
06/20Merck KGaA Partners With Alibaba Health in China
DJ
06/18How U.S. tax reform rewards companies that shift profit to tax havens
RE
06/14STRYKER : Says It Isn't in Deal Talks -- WSJ
DJ
06/13STRYKER : Says It Isn't in Deal Talks With Boston Scientific -- Update
DJ
06/13STRYKER : Says It's Not in Deal Talks with Boston Scientific
DJ
More sector news : Advanced Medical Equipment & Technology - NEC
4-Traders Strategies on ILLUMINA 
ILLUMINA - 02/16
The trend should regain control
BUY
ILLUMINA - 2017
There is still some upside potential
BUY
More Strategies
Latest Tweets
01:17a$ILMN ALERT: New Illumina, Inc. SEC Filing From our Stock News Alerts App 
06/18$786.19 Million in Sales Expected for Illumina, Inc. $ILMN This Quarter  
06/18$786.19 Million in Sales Expected for Illumina, Inc. $ILMN This Quarter  
06/18Leerink Swann Raises Illumina Q1 2019 Earnings Estimates to $1.65 EPS (Previo.. 
06/15Insider Selling: Illumina, Inc. $ILMN SVP Sells 10,500 Shares of Stock  
More tweets
Qtime:84
News from SeekingAlpha
06/06Is It Too Late To Buy Illumina Stock? 
05/31Myriad Genetics To Acquire Counsyl For Women's Reproductive Screening 
05/27WEEK IN REVIEW : Grail, An Oncology Diagnostics Company, Taps China Investors Fo.. 
05/17INSTITUTIONAL TOP IDEAS SERIES : Opaleye Management 
05/15Illumina buys Edico Genome 
Chart ILLUMINA
Duration : Period :
Illumina Technical Analysis Chart | ILMN | US4523271090 | 4-Traders
Technical analysis trends ILLUMINA
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 19
Average target price 278 $
Spread / Average Target -1,5%
EPS Revisions
Managers
NameTitle
Francis A. deSouza President, Chief Executive Officer & Director
Jay T. Flatley Executive Chairman
Ostadan Omead Executive Vice President-Products & Operations
Sam A. Samad Chief Financial Officer & Senior Vice President
Mostafa Ronaghi Chief Technology Officer & Senior Vice President
Sector and Competitors
1st jan.Capitalization (M$)
ILLUMINA29.37%41 550
THERMO FISHER SCIENTIFIC9.94%83 985
DANAHER CORPORATION6.98%69 368
INTUITIVE SURGICAL32.41%54 745
BOSTON SCIENTIFIC CORPORATION31.59%45 009
ROYAL PHILIPS14.30%39 403